X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19) 19
male (16) 16
female (12) 12
middle aged (11) 11
aged (9) 9
adult (7) 7
animals (7) 7
medicine & public health (7) 7
oncology (7) 7
gastroenterology & hepatology (6) 6
japan (6) 6
cell line (5) 5
mice, inbred c57bl (5) 5
rheumatology (5) 5
arthritis, rheumatoid - pathology (4) 4
gastroenterology (4) 4
index medicus (4) 4
mice (4) 4
prognosis (4) 4
stomach cancer (4) 4
surgical oncology (4) 4
antimitotic agents (3) 3
antineoplastic agents (3) 3
cell division - drug effects (3) 3
expression (3) 3
fibroblasts - metabolism (3) 3
follow-up studies (3) 3
gastrectomy (3) 3
gastric cancer (3) 3
immunology (3) 3
stomach neoplasms - genetics (3) 3
stomach neoplasms - pathology (3) 3
stomach neoplasms - surgery (3) 3
survival rate (3) 3
synovial membrane - cytology (3) 3
synovial membrane - pathology (3) 3
treatment outcome (3) 3
adolescent (2) 2
analysis (2) 2
antigen (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - therapeutic use (2) 2
arthritis (2) 2
arthritis, rheumatoid - immunology (2) 2
arthritis, rheumatoid - metabolism (2) 2
benzamides (2) 2
cancer (2) 2
care and treatment (2) 2
cell biology (2) 2
cell culture techniques (2) 2
cells (2) 2
cells, cultured (2) 2
clinical trials (2) 2
collagenase (2) 2
crohns-disease (2) 2
diagnosis (2) 2
disease models, animal (2) 2
efficacy (2) 2
fibroblasts - immunology (2) 2
fibroblasts - pathology (2) 2
follow-up (2) 2
gene (2) 2
gene expression (2) 2
gene-expression (2) 2
genetic aspects (2) 2
health aspects (2) 2
hematology (2) 2
hepatology (2) 2
imatinib mesylate (2) 2
immunohistochemistry (2) 2
induction (2) 2
infections (2) 2
internal medicine (2) 2
lymphocytes (2) 2
medical colleges (2) 2
medical research (2) 2
medicine (2) 2
methotrexate (2) 2
neoplasm staging (2) 2
oligodeoxynucleotides (2) 2
oligonucleotides, antisense - pharmacology (2) 2
rats (2) 2
research (2) 2
reverse transcriptase polymerase chain reaction (2) 2
rna, messenger - analysis (2) 2
rodents (2) 2
sensitivity and specificity (2) 2
stomach neoplasms - mortality (2) 2
surgery (2) 2
t-lymphocyte subsets - immunology (2) 2
t-lymphocyte subsets - metabolism (2) 2
transcription (2) 2
tumors (2) 2
ultrasonography (2) 2
1945 (1) 1
5-fluorouracil (1) 1
abl gene (1) 1
activity index (1) 1
acupoints (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2008, Volume 9, Issue 3, pp. 215 - 221
Journal Article
Journal Article
BMC Gastroenterology, ISSN 1471-230X, 2013, Volume 13, Issue 1, pp. 122 - 122
Journal Article
Journal Article
Vaccine, ISSN 0264-410X, 2007, Volume 25, Issue 26, pp. 4914 - 4921
Journal Article
International Journal of Cancer, ISSN 0020-7136, 09/2000, Volume 89, Issue 5, pp. 411 - 417
Detection of free cancer cells in the peritoneal cavity by RT‐PCR using carcinoembryonic antigen (CEA) as a target gene is a more sensitive predictor of... 
Journal Article
Journal Article
International Journal of Hematology, ISSN 0925-5710, 2/2007, Volume 85, Issue 2, pp. 132 - 139
To evaluate the efficacy of imatinib in a practical setting, we registered 43 patients with newly diagnosed chronic myelogenous leukemia (CML) (group I) and 56... 
Imatinib | Medicine & Public Health | Hematology | Cytogenetic response | Chronic myelogenous leukemia | Oncology | New diagnosis | Molecular response | Previous diagnosis | CHRONIC-PHASE | EFFICACY | imatinib | chronic myelogenous leukemia | molecular response | new diagnosis | previous diagnosis | ALPHA PLUS CYTARABINE | cytogenetic response | CHRONIC MYELOID-LEUKEMIA | MESYLATE | INTERFERON-ALPHA | ABL GENE | RESISTANCE | MUTATIONS | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Piperazines - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Antineoplastic Agents - administration & dosage | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - diagnosis | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Adult | Female | Cytogenetic Analysis | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Creatine Kinase - blood | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - blood | Pyrimidines - administration & dosage | Japan | Imatinib Mesylate | Piperazines - adverse effects | Remission Induction | Disease-Free Survival | Adolescent | Pyrimidines - adverse effects | Aged | Benzamides | Antimitotic agents | Care and treatment | Creatine kinase | Analysis | Oncology, Experimental | Chronic myeloid leukemia | Research | Antineoplastic agents | Cancer
Journal Article
Journal Article